SIA "ExpPharmGroup"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedNo dividends were paid.
Summary of financial statements2014–2025
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||||||
| Total current assets | 557 | 583 | 12 | 115 623 | 75 056 | 217 116 | 382 207 | 248 466 | 259 748 | 75 166 | 102 084 | 280 568 |
| Total non-current assets | 0 | 0 | 0 | 24 614 | 20 560 | 48 345 | 69 069 | 61 081 | 53 093 | 45 322 | 37 550 | 29 779 |
| Total assets | 557 | 583 | 12 | 140 237 | 95 616 | 265 461 | 451 276 | 309 547 | 312 841 | 120 488 | 139 634 | 310 347 |
| Balance sheet — liabilities and equity | ||||||||||||
| Current liabilities | 377 | 502 | 1318 | 107 409 | 58 190 | 45 571 | 181 857 | 18 315 | 168 713 | 3193 | 3079 | 170 378 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 377 | 502 | 1318 | 107 409 | 58 190 | 45 571 | 181 857 | 18 315 | 168 713 | 3193 | 3079 | 170 378 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 645 | -99 | -1387 | 34 134 | 33 598 | 216 902 | 239 529 | 148 716 | -77 104 | -14 833 | 35 260 | 3414 |
| Total equity | 180 | 81 | -1306 | 32 828 | 37 426 | 219 890 | 269 419 | 291 232 | 144 128 | 117 295 | 136 555 | 139 969 |
| Income statement | ||||||||||||
| Sales revenue | 0 | 0 | 0 | 273 832 | 442 673 | 2 304 990 | 1 847 286 | 1 955 478 | 546 231 | 259 577 | 377 103 | 316 959 |
| Operating profit | 186 | -49 | -1333 | 43 011 | 35 126 | 394 352 | 304 264 | 186 791 | -58 185 | -26 441 | 25 068 | 6404 |
| Profit before income tax | 186 | -49 | -1337 | 45 005 | 33 598 | 378 713 | 287 029 | 180 442 | -59 604 | -11 537 | 39 335 | 3414 |
| Profit for the reporting year | 645 | -99 | -1387 | 34 134 | 33 598 | 216 902 | 239 529 | 148 716 | -77 104 | -14 833 | 35 260 | 3414 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||||||
| Employees | 0 | 0 | 0 | 1 | 1 | 2 | 3 | 4 | 5 | 4 | 2 | 2 |
| Calculated dividend | — | 0 | 0 | 0 | 29 000 | 34 438 | 190 000 | 126 903 | 70 000 | 12 000 | 16 000 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: SIA "ExpPharmGroup"
Overview
SIA "ExpPharmGroup" (reg. no. 40003855277) is a limited liability company. The company was registered in 2006 and has been in the register for 20 years. Registered address: Rīga, Sīmaņa iela 11 k-2 - 27.
Financial results
Revenue in 2025 was 316 959 €, down 15,9% on the previous year (377 103 €). Net profit for 2025 was 3414 € (1,1% of revenue). The company was profitable in 8 of the 12 published years. In 2025 the company had 2 employees. Revenue per employee was 158 480 €. At the end of 2025, total assets were 310 347 € and equity 139 969 € (45,1% of assets).
Management and owners
The company has one board member. The sole owner of the company is a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.